Nyxoah
Nyxoah is a medical technology company that develops and commercializes the Genio system, a leadless and battery-free hypoglossal neurostimulation therapy. The device is designed to treat patients with moderate to severe obstructive sleep apnea who have not tolerated or have failed traditional PAP therapy. The system functions as an implantable neurostimulator to address sleep-disordered breathing and its associated cardiovascular risks.
Healthtech
Medical Technology
Funding summary
- Total raised
- €66.0M
- Funding rounds
- 4
- Exit
- ipo
- Exit value
- €0
Investors in Nyxoah
Investors on record for Nyxoah. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Nyxoah?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors